We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVLR
401
DELISTED
Avalara, Inc.
AVLR
| $18.4M | 0.05% |
200,000
-120,600
| -38% | -$10.8M |
|
402
Coca-Cola Europacific Partners
CCEP
$45.4B
| $18.2M | 0.05% |
427,435
+12,222
| +3% | +$614K |
|
|
MRTX
403
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $18.2M | 0.05% |
260,270
-4,886
| -2% | -$362K |
|
404
Genmab
GMAB
$21B
| $18.1M | 0.05% |
564,588
-13,145
| -2% | -$462K |
|
405
Rezolute
RZLT
$400M
| $18.1M | 0.05% |
6,610,274
| – | – |
|
406
Qualcomm
QCOM
$201B
| $18.1M | 0.05% |
160,080
-94,788
| -37% | -$13M |
|
|
EWCZ
407
DELISTED
European Wax Center
EWCZ
| $18M | 0.05% |
975,000
| – | – |
|
408
NeoGenomics
NEO
$2.43B
| $17.9M | 0.05% |
2,073,414
-602,622
| -23% | -$5.98M |
|
|
MORF
409
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $17.8M | 0.05% |
630,200
| – | – |
|
410
Equifax
EFX
$19.6B
| $17.6M | 0.05% |
102,950
+24,033
| +30% | +$4.71M |
|
411
GE Aerospace
GE
$319B
| $17.6M | 0.05% |
456,861
-50,286
| -10% | -$2.21M |
|
412
Lantheus
LNTH
$6.58B
| $17.6M | 0.05% |
249,919
+185,780
| +290% | +$14.1M |
|
413
White Mountains Insurance
WTM
$4.88B
| $17.6M | 0.05% |
13,483
-605
| -4% | -$783K |
|
|
BERY
414
DELISTED
Berry Global Group, Inc.
BERY
| $17.5M | 0.05% |
410,036
-228,753
| -36% | -$11.5M |
|
415
Palomar
PLMR
$3.64B
| $17.5M | 0.05% |
208,592
-67,115
| -24% | -$4.93M |
|
416
PTC
PTC
$14.4B
| $17.4M | 0.05% |
166,564
+35,710
| +27% | +$4.07M |
|
417
Bio-Rad Laboratories Class A
BIO
$10.1B
| $17.4M | 0.05% |
41,717
-2,272
| -5% | -$1.13M |
|
418
A.O. Smith
AOS
$7.78B
| $17.1M | 0.05% |
351,647
-10,921
| -3% | -$627K |
|
419
Customers Bancorp
CUBI
$2.66B
| $16.9M | 0.05% |
573,309
+98,945
| +21% | +$3.5M |
|
420
Telos
TLS
$316M
| $16.8M | 0.05% |
1,894,779
+232,670
| +14% | +$2.14M |
|
421
ICICI Bank
IBN
$102B
| $16.8M | 0.05% |
803,038
-170,256
| -17% | -$3.6M |
|
422
Royal Caribbean
RCL
$66.7B
| $16.8M | 0.05% |
443,332
+8,852
| +2% | +$359K |
|
423
Sun Communities
SUI
$14.3B
| $16.8M | 0.05% |
124,137
-35,701
| -22% | -$5.65M |
|
424
DXC Technology
DXC
$1.92B
| $16.7M | 0.05% |
682,599
-11,317
| -2% | -$311K |
|
425
Enphase Energy
ENPH
$4.85B
| $16.7M | 0.05% |
60,211
+56,215
| +1,407% | +$15.2M |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.